The final episode navigates the complex legal and regulatory landscape surrounding micro-dosing in professional settings. Host A investigates how different companies are developing policies around employee micro-dosing, from tech startups to traditional corporations, while Host B examines emerging legislative frameworks and clinical trial regulations. The hosts analyze specific cases where micro-dosing policies have been challenged in court, workplace drug testing implications, and the evolution of corporate wellness programs. The discussion culminates in exploring potential future scenarios for regulation and standardization of micro-dosing practices.